All in One Drop

Resource Library

Reference Publications

  • Susanna Sihvonen, Markku Korpela, Anu Mustila, and Jukka Mustonen. The predictive value of rheumatoid factor isotypes; anti-cyclic citrullinated peptide antibodies and antineutrophil cytoplastic antibodies for mortality in patients with rheumatoid arthritis. Journal of Rheumatology. 32(11): 2089-2094. 2007
  • Ewa Berglin. Predictors of Disease Onset and Progression in Early Rheumatoid Arthritis. Department of Public Health, Umea Sweden. 2006
  • John F Marcelletti, Robert M Nakamura. Assessment of serological markers associated with rheumatoid arthritis; diagnostic autoantibodies and conventional disease activity markers. Clinical and Applied Immunology Reviews. 4(2): 109-123. 2003
  • J Vencovsky, S Machaceks, L Sedova, J Kafkova, J Gatterova, V Pesakova, S Ruzickova. Autoantibodies can be a prognostic marker of an erosive disease in early rheumatoid arthritis. Ann Rheum Dis. 62: 427-430. 2003
  • Solbritt Rantapaa-Dahlquist (et al). Antibodies Against Cyclic Citrullinated Peptide and IgA Rheumatoid Factor Predict the Development of Rheumatoid Arthritis. Arthritis & Rheumatism. 48(10): 2741-2749. 2003
  • Shmerling RH, Delbanco TL. How useful is the rheumatoid factor? Analysis of sensitivity, specificity, and predictive value. Arch Intern Med. 152(12): 2417-2420. 1992

SQI Publications

  • Lea P., Keystone E., Mudumba S., Kahama A., Ding S-F., Hansen J., Azad A.A., Wang S., Weber D. Advantages of Multiplex Proteomics in Clinical Immunology. The Case of Rheumatoid Arthritis: Novel IgX PLEX™ Planar Microarray Diagnosis.Clin Rev Allergy Immunol:
    DOI 10.1007/s12016-009-8189-z (Published on line: December 2009)
  • Lea P., O’Connor T.E.T., Smith K., Ricks, C. Automated quantitative microarray assay platforms.IVD Technology,
    15(9) 43 – 49 (2009):
  • Lea P. and Ling M. New molecular assays for cancer diagnosis and targeted therapy. Current Opinion in Molecular Therapeutics 10(3),
    251 – 259 (2008)
  • Ling M.M., Ricks C., Lea P. Multiplexing molecular diagnostics and immunoassays using emerging microarray technologies. Expert Rev. Mol. Diagn. 7(1), 87 – 98 (2007)

Conference Presentations

Clinical Diagnosis of Celiac Disease Biomarkers: Sensitivity and Specificity in a Novel 4-PLEX Planar Microarray Assay
Mudumba, Sasi; Lea, Peter

Sasi Mudumba PhD; Peter Lea PhD, SQI Diagnostics, 36 Meteor Drive, Toronto, ON M9W 1A4, Canada plea@sqidiagnostics.com

7th International Congress on AUTOIMMUNITY, Ljubljana, Slovenia: MAY 5–9, 2010

Clinical Utility to Monitor Anti-TNF Antibodies using Novel IgXPLEX Planar Microarray Diagnostics
Azad AA1; Mudumba S2; Lea P2

1. Azar A. Azad PhD, Mount Sinai Hospital, Pathology and Laboratory Medicine, 600 University Ave, Toronto, ON M5T 1X5 Canada
2. Sasi Mudumba PhD, Peter Lea PhD, SQI Diagnostics, 36 Meteor Drive, Toronto, ON M9W 1A4, Canada plea@sqidiagnostics.com

7th International Congress on AUTOIMMUNITY, Ljubljana, Slovenia: MAY 5–9, 2010

Early Diagnosis of CCP Auto-antibodies in a 5-PLEX Novel Planar Microarray RA Assay
Husni ME1, Mudumba S2, Lea P2

1. M. Elaine Husni MD MPH, Dept Rheumatic and Immunologic Diseases, 9500 Euclid Ave-A50, Cleveland Clinic, OH 44195, USA
2. 2. S. Mudumba PhD, Peter Lea PhD, SQI Diagnostics, 36 Meteor Drive, Toronto, ON M9W 1A4, Canada plea@sqidiagnostics.com

7th International Congress on AUTOIMMUNITY, Ljubljana, Slovenia: MAY 5–9, 2010

Multiplex Protein / Antibody Autoimmune Microarray Quantitation

P.Lea, SQI Diagnostics

A Novel Anti-Citrullinated Peptide Antibody Assay Using a Four-Analyte Multiplexed QuantiSpot™ Rheumatoid Arthritis Test System

P. Biessels, S. Mudumba, A. Kahama, S-F. Ding, M. Ling, Peter Lea. SQI Diagnostics; S. Wang, Cleveland Clinic, Ohio; A. Azad, K. Pritzker, Mount Sinai Hospital, Toronto; E. Keystone, Centre for Arthritis and Autoimmune Disease, Mount Sinai Hospital, Toronto, Canada

40th Oak Ridge Conference, American Association for Clinical Chemistry April 17–18, (2008)
SQI Poster (.pdf) »